NFLPA Demands Investigation Into Eagles' Medical Handling of Jalen Hurts' Blood Clots

The NFL considers the medical file on Jalen Hurts closed, maintaining that the Philadelphia Eagles acted conservatively when they cleared their franchise quarterback to play one international game with a blood clot. The NFL Players Association sees a life-threatening failure of protocol, formally demanding a full investigation into how a localized calf issue was allowed to escalate into a pulmonary emergency.[1][2][3]

The union's intervention on October 20 escalates a medical situation the league had seemingly resolved. The NFL previously informed the union that it did not plan to review the medical care Hurts received, and a league source confirmed the Eagles will not face disciplinary action.[1][2]

"Before conclusions are drawn about how this situation was handled, there must be a full investigation into what occurred," an NFLPA spokesperson said. "Determining the facts is essential to ensuring players receive the highest level of care and protection going forward."[1][3]

The timeline of the 28-year-old's medical care is at the center of the dispute. Hurts was initially diagnosed with one superficial blood clot in his calf following a Week 4 game. Despite the diagnosis, he was cleared to take the field for the Eagles' October 11 matchup against the Jacksonville Jaguars in London.[2][3]

Following the international game, the clot traveled to his lungs, developing into multiple clots. The Eagles placed the quarterback on injured reserve indefinitely, and his agent confirmed he must avoid physical exertion while taking blood thinners. The escalation from a manageable calf issue to a season-ending emergency triggered the union's scrutiny.[1][3]

The NFL has publicly defended the Eagles' medical staff, characterizing their approach as appropriately guarded. League officials maintain that team physicians consulted with independent doctors and the Cleveland Clinic in London throughout the process, arguing that the clearance protocols did not run afoul of established safety standards.[1][2]

"The NFLPA is not aware of any NFL investigation into the medical care provided to Jalen Hurts," the union noted in its statement. "In fact, the league previously informed the union that it did not plan to review the care he received."[1][3]

The union's demand highlights a fundamental tension over who determines the adequacy of player safety protocols. While the league considers the matter resolved, the NFLPA continues to publicly pressure the NFL to reopen the case and conduct a transparent review of the medical decisions.[1][2]

The dispute centers on whether the league will yield to the union's demands and launch a formal inquiry into the timeline of events. The NFLPA maintains that determining the exact facts of the clearance process is the only way to ensure players receive adequate protection going forward.[1][3]

For now, the Eagles face no league sanctions, and the franchise continues to navigate a slow 2-4 start to the 2026 season without their starting quarterback. Hurts remains sidelined indefinitely as he recovers from the multiple clots, with his long-term playing future dependent on his response to the medication.[1][3]